chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Both me and my wife hands were red; This is a spontaneous report from a contactable consumer (patient's husband). An elderly female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on an unknown date) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have covid prior vaccination. Patient had no allergies. The patient's hands were slightly red for two days on 09Feb2021. No treatment received for the event. The outcome of the event was resolved on an unspecified date in 2021.  Information on the lot/batch number has been requested.
In the weeks following my shot, I am feeling much discomfort and pain in my right shoulder blade, shoulder and neck.
Pt experienced two seizures on 2/21/19. They were diagnosed as febrile seizures. The first occurred at approximately 3:50 PM and the second at approximately 6:00 PM. His temperature prior to the second seizure was measured at 101 degrees (F). Both seizures lasted around 2 minutes and consisted of whole body shaking. His lips appeared to turn slightly blue during the second seizure. No discoloration was noted during the first seizure. Both seizures resulted in pt falling asleep for a period of time, and he was pretty tired the rest of the day and into the next day.
The Pfizer bottle had already been diluted, drawn up and administered to other patients. No vaccines left in Pfizer bottle. RN inadvertently re-diluted empty Pfizer bottle and vaccinated patient with only diluent.  Not realizing that the patient did not receive correct vaccination, the patient was observed for 15 minutes, no adverse effects seen during that time. This error was not discovered until the end of the day when staff was confirming the number of vials and wasted vaccinations matched up with the number of patients seen.
no adverse events, patient 17yrs old and moderna vaccine recommended at 18yrs old.
9 days after receiving MMR/ Var & HAVRIX pt. broke out in rash (red-pinpoint) over entire body. To Dr. - she compared rash to rash in derm. book. Dr. determined it was Rubeola. No testing or no tx done. Pt. was tired, grumpy & rash itched. Rash went away after 2-3 days. No further problems.
Child was inappropriately vaccinated at with Pfizer Age 5-11 in Nov. 2021 when child was 4 yrs old.
Pt came for second shot of Moderna Covid-19 vaccine. Rph accidently gave the pt Pfizer vaccine instead of Moderna for her second dose Pharmacist found the error when documented the CDC vaccination card. Rph immediately informed the pt about the mistake. The patient was monitored at the store as usual.  Rph followed up with the pt few days after her Pfizer shot; the pt experienced the pain at injection site, and feeling the same when she got her Moderna ( first dose) No major side effects found
runny nose; cold; fever; body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHEA (runny nose), NASOPHARYNGITIS (cold), PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headache) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00ZAZIA) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test negative.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced RHINORRHEA (runny nose), NASOPHARYNGITIS (cold), PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headache). At the time of the report, PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication include vitamin C and patient thinks the event experienced is not due to the vaccine because in Dec2020 it happened the same to her. There is no relevant Treatment medication provided.
w/in 10min of vax pt devel anaphylactic like rxn (gen hives & palpebral edema);epi given, rxn ceased w/in 15 min;
Immediate "medicine-y" taste in mouth, lasted about 15 minutes.  Given benadryl 50mg orally. Vitals checked, seen by PA and extended monitoring time
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown demographics. The patients concurrent condition, medical history and concomitant medications were not reported. On an unknown date the patients were vaccinated with improperly stored GARDASIL 9 (unknown lot/expiration), RECOMBIVAX HB (unknown lot/expiration) and ROTATEQ (unknown lot/expiration) (incorrect product storage). No adverse effects reported. The temperature and time frame were unknown. There were no previous temperature excursion. No product quality compliant reported.
Pt received Tdap at age 9.  Unable to contact parents to determine patient status post vaccine as phone numbers disconnected.  Letter sent via certified mail requesting parents contact office 10-22-07.  As of 12-17-07, no response.
16JUL92 pt recvd 1st dose of Engerix-B & immed devel weakness of the lt arm & aching; the next day devel shoulder & neck pain, improved 4 days later;
Flat rash on chest, neck, and jawline that was not itchy or raised. Not hives.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at this time. It was reported that no adverse reactions were reported by any patients. Reporter does not have details on how many patients were impacted or any information on patients.   This case was linked to MOD-2022-501575.
Feeling somewhat sick with body aches and fatigue. Restless. Can?t sleep even though I?m tired.
I have developed CMV retinitis.  I had a headache and then blurry vision.  I went to the eye doctor and they referred me to a retinal specialist.  I am now on an antiviral.
A rash slowly developed over the course of the day after and by 24 hours after the shot was very itchy. Over the next 24 hours, it doubled in size and intensity until it was burning and itching. I put an ice pack on it for a while and then used hydrocortisone. Benedryl has helped to lessen the itching / burning sensation, but it continues to spread down my arm.
Developed weakness in extremities at 11 days after flu vaccine. Neurology diagnosed patient w/ Guillain Barre Syndrome. Undergoing PT per Neurology.
Syncope, fainting, sweating, pt stated fear of needles, has happened in the past.
Patient with erythema papular scattered blanching rash, changing now with raised central small whitish papule on erythematous base. Mostly on trunk abdomen, face and scalp. Also with URI symptoms and bilateral otitis media. Appears like varicella rash, mild case. Follow up 02/04/05: Patient also has fever.
Pt expired in hospital on 3/23/22. He was vaccinated but developed COVID pneumonia in January.  He was initially treated with doc and methadone and remdesivir.  He eventually required mechanical ventilation and tracheostomy.  He had a history of atrial flutter and developed left lower extremity ischemia  requiring a thrombectomy. Continued to worsen from a respiratory standpoint.  He had some hemodynamic instability and became moribund and unresponsive. Family transitioned pt to comfort care and removed vent. He expired approximately 50 minutes later.
Received first dose of Moderna on 1/1, felt hot flashes, tachycardia and dizzy after 30 seconds but did not inform nurses. Felt better during the 15 minute waiting period but 10 minutes after felt bad. 1 hour after vaccine had an allergic reaction similar to his shellfish allergy: pale, tachycardia, itchy face, dizzy with blackspots and took Benadryl. Denies SOB and airway closing. Denies any reactions to other vaccine. Next dose scheduled for 1/29. As per CDC recommendations, he may get the 2nd dose of vaccine but will advise to stay for at least 30 minutes to monitor for symptoms.
Beginning at 6am the day after the vaccine, fever of 101.5-102, chills, sweats, headache, significant muscle pain, extreme fatigue, nausea with walking down a flight of stairs. Unable to work or conduct daily activities including eating, dog walking, etc. Last fever recorded of 101.7 at 6:30pm. Took Advil, Benadryl and Tylenol and dozed throughout the night. Woke up with no fever, but continued muscle ache and fatigue which slowly resolved throughout the day. At 8pm, symptoms are about 75% resolved. Moderate arm pain with redness, heat, swelling and pain at injection site starting the evening of the injection. Range of motion about 80%.
The day after the 2nd vaccine, I had chills, slight fever (98.8) and sensitive skin for 14 hours. On the 4th day after the second vaccine, I started experiencing dizziness. First time when I laid down to sleep at 10pm, I felt dizzy when I turned my head right or left. I slept on my back with head propped up for 3 nights, because the sensation continued when i moved my head right or left.  By the 7th day, most of the dizziness was minor and rare. After 10 days, I have felt slight dizziness on a rare occasion.   I don't recall have dizzy symptoms  prior to the vaccine.
Dizziness; Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FATIGUE (Feeling tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 22321) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Feeling tired). At the time of the report, DIZZINESS (Dizziness) and FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported.
headache. slow but then became a migraine for 3 days. frontal sinuses first around eyes and base of dorsal skull, then full blown migraine with nausea. and light sensitivity
Headache & Myalgia Narrative: dose 1:day 1-3 sore arm;day 1-2 ha &fatigue dose 2:day 1-3-ha, sore arm;fatigue;bodyache
A few minutes after providing vaccination, client reported feeling warm and appeared anxious. Client was offered water and fruit snacks to help with potential nausea. Client then fainted for a short period of time. Client regained consciousness and was alert and oriented x3. Client drank more water until dizziness subsided, and Mom and client remained under observation until client stated he was feeling better and able to stand up without any dizziness.
Developed hives over body within 3 hours of initial vaccine. Hives have been intermittent, site of vaccine is not affected. Also has increase in heart burn symptoms including nausea with vomiting and upper abdominal pain. At home, has been trying Tylenol, OTC benadryl, OTC allergra, and pepcid.  In clinic, given zofran follow by viscous lidocaine with AlMgH. Prescribed prednisone taper for home. Prescribed zofran for home for nausea.
Large red raised rash, approximately 4 in by 4 in; no itching; Symptoms resolved after 3 days, applied ice.
Approximately 60-90 seconds after receiving HPV vaccine patient had an episode of syncope. Patient was standing behind her mother, who was seated, and fell to the floor. Patient's head made an audible "thud" when it hit the floor. It appeared she struck the back of her head. Initially patient's eyes were rolled back and patient was twitching slightly. She then closed her eyes in an apparent loss of consciousness for 20-30 seconds. Patient did not respond to questions or commands during this episode. Approximately 90-120 seconds after start of episode patient became more alert and began sobbing. Emergency Department was called immediately and 2 ED RNs responded. Pt was transferred (wouldn't/couldn't stand) to wheel chair and taken to ED. Patient had received intranasal flu vaccine ~5 minutes prior to HPV. Patient's mother and 1 sibling witnessed event. Father and 2 other siblings were called to room by mother while patient was still on the ground. Patient was examined and observed in the Emergency Department for 4 hours. She was cleared for discharge to home in parents' care. Two or three days after event patient presented to outside hospital with reported altered mental status. Patient was found to have small subdural hematoma and was transferred to another hospital.
Fever increased 102 (ax) headache, neck stiffness and was referred to ED. Improvement noted within 12 hours when followed up at PMD office. Treatment recommended was ibuprofen, rest w/ fluids. Complete resolution of all symptoms within 48 hours.
A report was received from a health professional on 10/25/2002, concerning seven vaccinees who experienced red, burning, hard nodules at the site of injection after receiving Fluvirin on 10/22/2002. On 10/22/2002, 7 out of 68 employees who received Fluvirin at a Community Hospital experienced red, burnign, hard nodules at the site of injection within a few hours. The vaccinees were seen in the emergency room. The vaccinee was administered using a TS syringe with a prefixed needle. It was unknown if the vaccinees reocvered. The reporter suspects that these adverse effects are probably associated with this particular batch of Fluvirin. The following day, additonal employees received Fluvirin from a different batch and no adverse effects were noted. Update1. 02/20/2003: A report was received from a health care professional concerning a vaccinee of unknown demography who experienced raised, red induration at the injection site 15 minutes after receiving Fluvirn on an unknown date. The vaccinee had recovered at the report. Three other vaccinees had the same reaction  to the same batch. There was insufficient information to determine the reporters causality assessment.  See Reference: PJP2002000541, PJP200300088, PJP200300090.
On 5/1/80, pt recv vax and on 5/4/80, pt expired.  Pt exp no fever, no crying, and no symptoms.
Fever of 100.4; Chills; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received first dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH; lot number: EN6207) via an unspecified route of administration in the left arm on 16Mar2021 at 16:45 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included high blood pressure and high cholesterol. The patient was allergic to codeine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. the concomitant medications included Pravastatin (MANUFATURER UNKNOWN), Hydrochlorothiazide (MANUFACTURER UNKNOWN), Olmesartan (MANUFACTURER UNKNOWN). On 17Mar2021, at 16:45, the patient experienced fever of 100.4 (unspecified units), chills and headache. The patient received ASPIRIN as a treatment for the adverse events. The clinical outcome of the events fever 100.4, chills and headache were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
upset stomach; constipation; Pain in right arm where I received the Moderna Covid-19 vaccine; A spontaneous report was received from a healthcare professional concerning a male  patient  of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in right arm where i received the moderna covid-19 vaccine/vaccination site pain, constipation, upset stomach.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) Pain in right arm where I received the Moderna Covid-19 vaccine, constipation, upset stomach.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pain in right arm where i received the moderna covid-19 vaccine, constipation, upset stomach was unknown.
Sore throat; Fever; Very tired; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection), via unspecified route of administration, on an unspecified date (Lot Number: not reported) as a dose 1, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. On an unspecified date the patient experienced sore throat, fever and was very tired. Reporter stated that he was calling on a friend from work and did not know what shot patient took. Reporter thought that patient took Moderna or whatever and did not know patient might have taken the Pfizer. Reporter stated that patient had a sore throat and his son-in-laws said patient had a fever too and was very tired lately and patient was old. Reporter had not talk with patient about it and it was a week and patient had some symptoms. Reporter queried some information that what should be told to patient. Reporter was provided with the number of Pfizer Medical Information. The outcome for all the reported events was unknown.  No follow-up attempts are possible. No further information is expected.
After second vaccine felt nauseous for 2 hours; vomit two times; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received bnt162b2 (brand: PFIZER), dose 2 via an unspecified route of administration, administered in left arm on 08Feb2021 (lot number: EM9808) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No known allergies. The patient previously received 1st dose of bnt162b2 (brand: PFIZER, lot number: EL3247) on 18Jan2021 04:30 PM for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. After second vaccine felt nauseous for 2 hours and vomit two times on 13Feb2021 23:30. Outcome of events was recovering. No treatment was given for the events. The patient was not diagnosed of covid prior vaccination and has not been tested for covid post vaccination.
Swelling and induration over site of Varicella Vaccine resulting in two ER visits
While patient was being observed after receiving Johnson and Johnson vaccine he complained of nausea and requested evaluation by EMS. Upon evaluation by EMS patient was noted to have low heart rate of 35 bpm.  EMS administered Atropine and transported resident to local hospital.
I have no history of any heart related health problems. In January I developed hypertension. My blood pressure was regularly 220/150. It has taken months to control it with medication and I will likely be on these medications for a very long time if not the rest of my life.
Swelling left deltoid 5x7 cm with redness.  Had swelling right deltoid also-now normal
I felt fine immediately after vaccine but a few hours later I had severe swelling on the left arm at the point of entry, and a lot of pain. I started to feel light headed and nauseus, loss of balance. This was followed by chills in the evening before bedtime around 9pm, had shivering and shaking for about 4.5 hours when it finally broke about 1:30AM CST.
A non-serious report of expired FluMist administered was received from a medical assistant concerning an adult female. No medical or drug history was reported. The patient received FluMist on 08-Jan2008 it was determined that the FluMist was passed the expiry date. No adverse events were reported. No information was provided regarding additional dosing with unexpired FluMist. The reporter did not provide a causality assessment. The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
01/12/2023  PATIENT CALLED HEALTH DEPARTMENT TO REPORT SHE DEVELOPED A RASH/HIVES ONE WEEK AFTER RECEIVING THE ABOVE MENTIONED VACCINES ON HER NECK, ARMES, TORSO AND AREA ABOVE HER KNEES.  PATIENT CALLED MD AND WAS GIVEN A PRESCRIPTION OF PREDISONE FOR SIX DAYS AND TOPICAL CREAM FOR ITCHING.  NO OTHER SYMPTOMS REPORTED.  PATIENT HAS F/U APPOINTMENT IN ONE WEEK TO RECEIVE SECOND DOSE OF HEPATITIS B AND COVID.  PT TOLD TO CALL MD TO GET A NOTE SAYING SHE CAN RECEIVE VACCINES BEFORE WE GIVE FOLLOW UP.  PT HAS MD APPOINTMENT ON 01/24/2023.
Received flu vaccination thru Employer Clinic. Injection given by MD but felt immediate pain. Indicates location of injection was too high near shoulder joint. Pain persistent range of motion limited and pain when sleeping on left arm. Noting tingling in left hand.
Nurse who administered my vaccination did so way to high on my right shoulder, near joint. Pain felt immediately leading to loss of use in left arm, frozen shoulder. Surgery required to release frozen shoulder and re attach left bicep muscle. Pain continues on a daily basis. I have 90% recovered.